Biogen (BIIB) Tops Q1 EPS by $1.40
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $213.48 -3.33%
Revenue Growth %: +4.3%
Financial Fact:
Total revenues: 2.96B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +4.3%
Financial Fact:
Total revenues: 2.96B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $9.14, $1.40 better than the analyst estimate of $7.74. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.41 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)
- HSBC lifts S&P 500 year-end target
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
